US 8828717
Framework residue substituted humanized COL-1 antibodies and their use
granted A61KA61K2039/505A61P
Quick answer
US patent 8828717 (Framework residue substituted humanized COL-1 antibodies and their use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00